Royal London Asset Management Ltd. Sells 10,284 Shares of UnitedHealth Group Incorporated $UNH

Royal London Asset Management Ltd. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 745,305 shares of the healthcare conglomerate’s stock after selling 10,284 shares during the period. UnitedHealth Group comprises about 0.6% of Royal London Asset Management Ltd.’s investment portfolio, making the stock its 25th biggest holding. Royal London Asset Management Ltd.’s holdings in UnitedHealth Group were worth $309,771,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the company. Toth Financial Advisory Corp increased its position in shares of UnitedHealth Group by 25.0% during the 2nd quarter. Toth Financial Advisory Corp now owns 26,164 shares of the healthcare conglomerate’s stock valued at $10,874,000 after purchasing an additional 5,232 shares during the last quarter. Mufg Securities Americas Inc. increased its holdings in UnitedHealth Group by 9.1% during the second quarter. Mufg Securities Americas Inc. now owns 27,352 shares of the healthcare conglomerate’s stock valued at $11,368,000 after buying an additional 2,292 shares during the last quarter. Nissay Asset Management Corp Japan boosted its stake in shares of UnitedHealth Group by 2.3% during the 2nd quarter. Nissay Asset Management Corp Japan now owns 120,615 shares of the healthcare conglomerate’s stock worth $50,131,000 after acquiring an additional 2,678 shares during the last quarter. Campbell Newman Asset Management Inc. purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth $45,411,000. Finally, Field & Main Bank bought a new stake in UnitedHealth Group during the second quarter valued at about $3,926,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

UNH stock opened at $393.99 on Friday. The company has a market capitalization of $353.64 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 1.36 and a beta of 0.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The business has a 50 day simple moving average of $413.28 and a two-hundred day simple moving average of $360.11.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. Wall Street Zen raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Morgan Stanley raised their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a research note on Friday, July 17th. DA Davidson set a $512.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and raised their price objective for the company from $287.00 to $453.00 in a research report on Thursday, July 16th. Finally, HSBC upped their target price on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a report on Monday, July 6th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $456.56.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.